Wells Fargo Maintains Outperform on Cardlytics, Raises Price Target to $46

Wells Fargo maintains Cardlytics (NASDAQ:CDLX) with a Outperform and raises the price target from $40 to $46.

Benzinga · 11/13/2019 14:30

Wells Fargo maintains Cardlytics (NASDAQ:CDLX) with a Outperform and raises the price target from $40 to $46.